Patents by Inventor Aritra Pal

Aritra Pal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAS TURBINE ENGINE COMBUSTOR WITH DILUTION PASSAGES
    Publication number: 20240133553
    Abstract: A combustor including an annular liner, a dome wall, a combustion chamber, at least one fuel cup and at least one dilution passage. The fuel cup being provided on the dome wall and being fluidly coupled to the combustion chamber. The fuel cup defining a fuel cup centerline. The at least on dilution passage terminating in at least on slot opening onto the dome wall, with the at least one slot having a longitudinal body axis.
    Type: Application
    Filed: October 19, 2022
    Publication date: April 25, 2024
    Inventors: Pradeep Naik, Perumallu Vukanti, Michael T. Bucaro, Sibtosh Pal, Michael A. Benjamin, Bhavya Naidu Panduri, Aritra Chakraborty, Pabitra Badhuk
  • ANTI-TREM2 ANTIBODIES AND RELATED METHODS
    Publication number: 20230287110
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: October 7, 2022
    Publication date: September 14, 2023
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta
  • Anti-TREM2 antibodies and related methods
    Patent number: 11505602
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: November 22, 2022
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta
  • METHODS OF USING ANTI-TREM2 ANTIBODIES
    Publication number: 20210317211
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: June 10, 2021
    Publication date: October 14, 2021
    Inventors: Michel Streuli, Leonard G. Presta, Venkataraman Sriram, Aritra Pal, Nadine Jahchan, Mikhail Binnewies, Joshua L. Pollack, Xiaoyan Du
  • ANTI-TREM1 ANTIBODIES AND RELATED METHODS
    Publication number: 20210101983
    Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: October 8, 2020
    Publication date: April 8, 2021
    Inventors: Christopher Chan, Aritra Pal, Venkataraman Sriram, Leonard G. Presta, Tiep Tu Le, Linda Liang
  • Anti-TREM1 antibodies and related methods
    Patent number: 10836828
    Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: November 17, 2020
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Christopher Chan, Aritra Pal, Venkataraman Sriram, Leonard G. Presta, Tiep Tu Le, Linda Liang
  • ANTI-TREM1 ANTIBODIES AND RELATED METHODS
    Publication number: 20200255529
    Abstract: Provided herein are anti-TREM1 antibodies and related methods of making and using anti-TREM1 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM1 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: April 17, 2020
    Publication date: August 13, 2020
    Inventors: Christopher CHAN, Aritra PAL, Venkataraman SRIRAM, Leonard G. PRESTA, Tiep Tu LE, Linda LIANG
  • ANTI-TREM2 ANTIBODIES AND RELATED METHODS
    Publication number: 20200140546
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: October 14, 2019
    Publication date: May 7, 2020
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta
  • Anti-TREM2 antibodies and related methods
    Patent number: 10508148
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: December 17, 2019
    Assignee: Pionyr Immunotherapeutics, Inc.
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta
  • ANTI-TREM2 ANTIBODIES AND RELATED METHODS
    Publication number: 20190309064
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, comprising killing, disabling, or depleting non-stimulatory myeloid cells using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: May 9, 2019
    Publication date: October 10, 2019
    Inventors: Michel Streuli, Venkataraman Sriram, Aritra Pal, Leonard G. Presta